News
TNDM
30.43
-1.62%
-0.50
TNDM Crosses Above Average Analyst Target
NASDAQ · 2d ago
Weekly Report: what happened at TNDM last week (0408-0412)?
Weekly Report · 4d ago
Press Release: Tandem Diabetes Care to Announce First Quarter 2024 Financial Results on May 2, 2024
Tandem Diabetes Care to Announce First Quarter 2024 Financial Results on May 2, 2024. The Company will hold a conference call and simultaneous webcast to discuss its first quarter 2024 financial and operating results after the financial markets close. Tandem is a leading insulin delivery and diabetes technology company.
Dow Jones · 04/09 20:12
Tandem Diabetes Care to Announce First Quarter 2024 Financial Results on May 2, 2024
Tandem Diabetes Care, Inc. Plans to release its first quarter 2024 results after the financial markets close on Thursday, May 2, 2024. The Company will hold a conference call and simultaneous webcast to discuss its financial and operating results. A live webcast of the call will be available on the company's Investor Center website.
Barchart · 04/09 15:05
Weekly Report: what happened at TNDM last week (0401-0405)?
Weekly Report · 04/08 11:23
What 4 Analyst Ratings Have To Say About Tandem Diabetes Care
Tandem Diabetes Care (NASDAQ:TNDM) has an average price target of $32.5. The company designs, manufactures, and markets durable insulin pumps for diabetes patients. 4 analysts have recently shared their insights on Tandem diabetes care. The firm has a 12-month price target for the company with an average of $24.25.
Benzinga · 04/03 20:00
Tandem Diabetes Care Price Target Raised to $38.00/Share From $31.00 by Citigroup
Dow Jones · 04/03 18:45
Tandem Diabetes Care Is Maintained at Neutral by Citigroup
Dow Jones · 04/03 18:45
Citigroup Maintains Neutral on Tandem Diabetes Care, Raises Price Target to $38
Benzinga · 04/03 18:35
Analysts Are Bullish on These Healthcare Stocks: Tandem Diabetes Care (TNDM), Apyx Medical (APYX)
TipRanks · 04/02 13:00
Tandem Diabetes (TNDM) Gains From Innovation Amid Macro Issues
NASDAQ · 04/01 14:41
Weekly Report: what happened at TNDM last week (0325-0329)?
Weekly Report · 04/01 11:21
Inari Medical (NARI) Up 4% Since Last Earnings Report: Can It Continue?
NASDAQ · 03/29 15:30
Insulet: Insulating Patients, Investors Still Have To Wait
Insulet Corporation is the maker of the Omnipod Insulin Management System. The company has five-folded the business over the past decade. Insulet's sales and operating profits have been strong, but expectations for future growth have been high. The wearable and discrete solution has potential for further adoption in the diabetes market.
Seeking Alpha · 03/28 13:44
Stocks Inch Higher, Tesla Rebounds, Bitcoin Holds Below $70,000: What's Driving Markets Tuesday?
The S&P 500 is set to break a two-day losing streak on Tuesday, up 0.3% during midday trading in New York. The Dow Jones Industrial Average, the Nasdaq 100 and the Russell 2000 all experienced a 0.2% rise. Market volatility remained remarkably low, with the VIX index holding below the 13 mark. New orders for manufactured durable goods increased by 1.4% month-over-month in February 2024.
Benzinga · 03/26 18:08
Stocks Inch Higher After February's US Durable Goods Orders Released
NASDAQ · 03/26 14:36
Tesla, Krispy Kreme, McCormick And Other Big Stocks Moving Higher On Tuesday
U.S. Stocks were higher on Tuesday. Shares of Tesla Inc (TSLA) rose sharply amid reports suggest Italy has approached the company about electric truck production. The Dow Jones index gained around 50 points in Tuesday's session. Krispy Kreme, Inc. Shares rose 21.3% to $15.10. Praxis Precision Medicines Inc (PRAX) shares jumped 31.9%.
Benzinga · 03/26 14:36
Correction to Tandem Diabetes Care Rating
Dow Jones · 03/26 14:33
Stifel Upgrades Tandem Diabetes Care to Buy, Raises Price Target to $37
Benzinga · 03/26 14:15
Tandem Diabetes raised to Buy at Stifel on Mobi launch
Stifel upgraded Tandem Diabetes Care to Buy from Hold. Analyst cites higher-than-expected demand for the company's automated insulin pump, Mobi. Mobi is the world's smallest durable automated insulin delivery system. The medical device maker traded 5% higher premarket Tuesday.
Seeking Alpha · 03/26 13:29
More
Webull provides a variety of real-time TNDM stock news. You can receive the latest news about Tandem Diabetes through multiple platforms. This information may help you make smarter investment decisions.
About TNDM
Tandem Diabetes Care, Inc. is a global insulin delivery and diabetes technology company, which manufactures and sells advanced automated insulin delivery systems. Its pump portfolio features the Tandem Mobi system and the t:slim X2 insulin pump, both of which feature Control-IQ advanced hybrid closed-loop technology. Its t:slim X2 and Tandem Mobi pumps can be used with a variety of infusion sets to offer patients choice in how and where their pump is worn. In addition, they are software updatable from a personal computer and compatible with its Web-based data management application. Both pumps feature its Control-IQ advanced hybrid closed loop technology, with an automated insulin delivery (AID) feature designed to help increase a user's time in targeted glycemic range. There are two primary therapies used by people with insulin-dependent diabetes, Multiple Daily Injection (MDI) and insulin pumps. As part of it AID systems, it offers pump integration with multiple CGM sensors.